Xponance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Buy |
197,930
+6,727
| +4% | +$5.24M | 1.29% | 10 |
|
|
2025
Q1 | $158M | Buy |
191,203
+4,673
| +3% | +$3.86M | 1.53% | 10 |
|
|
2024
Q4 | $144M | Sell |
186,530
-159
| -0.1% | -$123K | 1.31% | 10 |
|
|
2024
Q3 | $165M | Sell |
186,689
-8,135
| -4% | -$7.21M | 1.6% | 10 |
|
|
2024
Q2 | $176M | Sell |
194,824
-262
| -0.1% | -$237K | 1.8% | 8 |
|
|
2024
Q1 | $152M | Buy |
195,086
+4,077
| +2% | +$3.17M | 1.59% | 8 |
|
|
2023
Q4 | $111M | Buy |
191,009
+1,718
| +0.9% | +$1M | 1.33% | 10 |
|
|
2023
Q3 | $102M | Buy |
189,291
+590
| +0.3% | +$317K | 1.38% | 9 |
|
|
2023
Q2 | $88.5M | Buy |
188,701
+21,738
| +13% | +$10.2M | 1.18% | 11 |
|
|
2023
Q1 | $57.3M | Buy |
166,963
+4,192
| +3% | +$1.44M | 0.84% | 16 |
|
|
2022
Q4 | $59.5M | Buy |
162,771
+16,459
| +11% | +$6.02M | 0.96% | 14 |
|
|
2022
Q3 | $47.3M | Buy |
146,312
+10,436
| +8% | +$3.37M | 0.91% | 13 |
|
|
2022
Q2 | $44.1M | Buy |
135,876
+748
| +0.6% | +$243K | 0.89% | 13 |
|
|
2022
Q1 | $38.7M | Buy |
135,128
+15,489
| +13% | +$4.44M | 0.64% | 21 |
|
|
2021
Q4 | $33M | Sell |
119,639
-3,063
| -2% | -$846K | 0.52% | 31 |
|
|
2021
Q3 | $28.4M | Sell |
122,702
-11,206
| -8% | -$2.59M | 0.54% | 28 |
|
|
2021
Q2 | $30.7M | Sell |
133,908
-15,512
| -10% | -$3.56M | 0.56% | 25 |
|
|
2021
Q1 | $27.9M | Sell |
149,420
-455
| -0.3% | -$85K | 0.59% | 30 |
|
|
2020
Q4 | $25.3M | Buy |
149,875
+851
| +0.6% | +$144K | 0.55% | 31 |
|
|
2020
Q3 | $22.1M | Sell |
149,024
-7,957
| -5% | -$1.18M | 0.54% | 33 |
|
|
2020
Q2 | $25.8M | Buy |
+156,981
| New | +$25.8M | 0.67% | 25 |
|